文献速递儿科与产科急症

急诊科治疗犬缓解儿童焦虑:一项随机临床试验

Therapy Dogs for Anxiety in Children in the Emergency Department: A Randomized Clinical Trial.
PubMed 文献 · JAMA Netw Open · 2025-03-03
一句话结论在标准儿童医疗辅导基础上加用治疗犬约10分钟,可小幅但显著降低儿科急诊患儿由儿童自评和家长评估的焦虑。

该随机临床试验于2023年2月1日至2024年6月30日在学术性儿科急诊开展,纳入80例5-17岁疑似中度至高度焦虑患儿,对照组和干预组各40例,所有患儿均接受标准儿童医疗辅导,干预组额外接触治疗犬及训导员约10分钟。从基线(T0)到45分钟(T1),儿童自评FACES焦虑评分对照组平均变化-1.5分 vs 干预组-2.7分(P=0.02),家长评估对照组-1.8分 vs 干预组-3.2分(P=0.008);FACES评分下降超过2.5分的比例对照组9例(23%) vs 干预组18例(46%)(P=0.04)。至120分钟(T2),两组儿童自评FACES评分分别降至3.6分和3.0分(P=0.70);对照组14例(35%)使用氯胺酮、咪达唑仑、劳拉西泮或氟哌利多 vs 干预组7例(18%)(P=0.08)。作者认为这些发现支持使用治疗犬帮助减轻疼痛和焦虑,而不使用化学或物理约束。

要点

  • 在标准儿童医疗辅导基础上加用治疗犬约10分钟,儿童自评FACES焦虑评分从T0到T1对照组平均下降1.5分 vs 干预组下降2.7分(P=0.02)。
  • 家长评估的患儿焦虑从T0到T1对照组平均下降1.8分 vs 干预组下降3.2分(P=0.008)。
  • FACES评分下降超过2.5分的患儿比例对照组9例(23%) vs 干预组18例(46%)(P=0.04,Fisher检验)。
  • 至T2(120分钟)儿童自评FACES评分对照组3.6分 vs 干预组3.0分(P=0.70),两组间无显著差异。
  • 使用氯胺酮、咪达唑仑、劳拉西泮或氟哌利多的比例对照组14例(35%) vs 干预组7例(18%)(P=0.08,Fisher检验)。

适用人群与场景

  • 5-17岁、疑似中度至高度焦虑、在学术性儿科急诊就诊的儿童;所有参与者均接受标准儿童医疗辅导。

诊断标准与关键阈值

  • 焦虑采用0-10分FACES量表评估,0分表示无焦虑,10分表示非常严重的焦虑;同时测量唾液皮质醇浓度。
  • 测量时间点为基线(T0)、45分钟(T1)和120分钟(T2),同时采集儿童和家长的样本。

处置流程与药物剂量

  • 所有参与者接受标准儿童医疗辅导;干预组随机分配额外接触治疗犬及训导员约10分钟。

研究设计与关键结果

  • 随机临床试验,共纳入80例患儿(平均[SD]年龄10.9[3.8]岁;45例[56%]为女性),对照组40例、干预组40例;T0时儿童自评FACES评分平均(SD)为5.4(2.8)分,家长评估为6.4(2.4)分,组间无差异。
  • 从T0到T1,儿童自评焦虑变化:对照组平均(SD)-1.5(3.4)分 vs 干预组-2.7(2.5)分(P=0.02,Mann-Whitney U检验);家长评估的患儿焦虑变化:对照组-1.8(2.7)分 vs 干预组-3.2(2.3)分(P=0.008)。
  • FACES评分下降超过2.5分的比例:对照组9例(23%) vs 干预组18例(46%)(P=0.04,Fisher检验)。
  • T2时儿童自评FACES评分平均(SD):对照组降至3.6(3.4)分 vs 干预组3.0(2.7)分(P=0.70)。
  • 使用氯胺酮、咪达唑仑、劳拉西泮或氟哌利多的比例:对照组14例(35%) vs 干预组7例(18%)(P=0.08,Fisher检验)。
  • 儿童和家长唾液皮质醇从T0到T1在两组均下降,但组间无差异;家长唾液皮质醇持续显著高于患儿唾液皮质醇(P<0.001,非配对t检验,两组T0和T1儿童 vs 家长比较)。

证据类型、等级与局限

  • 研究类型:随机临床试验(ClinicalTrials.gov注册号NCT03784573)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,这些发现支持使用治疗犬帮助减轻疼痛和焦虑,而不使用化学或物理约束。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Prior evidence suggests that the use of therapy dogs in emergency care reduces anxiety in adults, but no trial has tested the use of therapy dogs in emergency care of children.

OBJECTIVE: To examine whether adjunctive use of therapy dogs in standard child-life therapy reduces child-reported and parent-reported child anxiety in a pediatric emergency department (ED).

DESIGN, SETTING, AND PARTICIPANTS: This randomized clinical trial was conducted from February 1, 2023, to June 30, 2024, at an academic pediatric ED. Children (aged 5-17 years) with suspected moderate to high anxiety were included.

INTERVENTION: All participants received standard child-life therapy, and the intervention group was randomly assigned to have exposure to a therapy dog and handler for approximately 10 minutes.

MAIN OUTCOMES AND MEASURES: Anxiety was measured using the 0- to 10-point FACES scale (with 0 indicating no anxiety and 10 indicating very severe anxiety) and salivary cortisol concentrations. Measurements were obtained at baseline (T0), 45 minutes (T1), and 120 minutes (T2) for both child and parents.

RESULTS: A total of 80 patients (mean [SD] age, 10.9 [3.8] years; 45 [56%] female) were enrolled (40 in the control group and 40 in the intervention group). At T0, the mean (SD) FACES scores were 5.4 (2.8) for child report and 6.4 (2.4) for parent report; the means were not different between groups. From T0 to T1, child-reported anxiety changed by a mean (SD) of -1.5 (3.4) points in the control group vs -2.7 (2.5) points in the intervention group (P = .02, Mann-Whitney U test); similarly, mean (SD) parent-estimated child anxiety changed by -1.8 (2.7) points in the control group vs -3.2 (2.3) points in the intervention group (P = .008). A total of 9 children (23%) in the control group had a greater than 2.5-point decrease in FACES score vs 18 (46%) in intervention group (P = .04, Fisher test). At T2, mean (SD) child-reported FACES scores decreased to 3.6 (3.4) points in the control group and 3.0 (2.7) points in the intervention group (P = .70). A total of 14 control participants (35%) received ketamine, midazolam, lorazepam, or droperidol vs 7 (18%) in the intervention group (P = .08, Fisher test). Child and parent salivary cortisol decreased from T0 to T1 in both groups but was not different between groups. Parental salivary cortisol was significantly consistently higher than their children's salivary cortisol (P < .001, unpaired t test, for comparisons of child vs parent at T0 and T1 in both groups).

CONCLUSIONS AND RELEVANCE: This study of adjunctive use of therapy dogs in standard child-life therapy found a modest but significantly greater reduction in both child-reported and parental-reported child anxiety in the pediatric ED for the intervention vs control group. These findings support the use of therapy dogs to help reduce pain and anxiety without the use of chemical or physical constraint.

TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03784573.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Kelker HP, Siddiqui HK, Beck AM, et al. Therapy Dogs for Anxiety in Children in the Emergency Department: A Randomized Clinical Trial. JAMA Netw Open. 2025. PMID: 40085085. doi:10.1001/jamanetworkopen.2025.0636

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。